Progyny, Inc. (PGNY) saw its stock drop sharply after reporting worse-than-expected third-quarter sales results and issuing FY24 revenue guidance below analyst estimates. The company blamed lower-than-expected utilization rates for the shortfall. Despite the disappointing results, Progyny remains optimistic about its long-term prospects in a growing market. Analysts have reacted to the news by adjusting their price targets on PGNY stock.
